Phase 1 clinical trial dosing of first patient complete; primary objective to assess safety/tolerability and absolute bioavailability of TH104Phase 1 study expected to be completed in 1Q24 with topline readout in 2Q24Company fully funded into 2025 with…
Read MoreMCLEAN, VA / ACCESSWIRE / February 5, 2024 / Gladstone Investment Corporation (Nasdaq:GAIN) announces the following event:What:Gladstone Investment Corporation’s Third Fiscal Quarter Ended December 31, 2023 Earnings Call & Webcast When:Wednesday, F…
Read MoreVICTORIA, BC / ACCESSWIRE / February 5, 2024 / Boron One Holdings Inc. (“Boron One” or the “Company”) (TSXV:BONE), a company dedicated to the decarbonization of Planet Earth through the responsible utilization of its boron assets, i…
Read MoreGARBSEN, GERMANY / ACCESSWIRE / February 5, 2024 / ARRALYZE®, the Life Science arm of LPKF Laser & Electronics SE, proudly announces the commercial availability of the CellShepherd®. After a successful beta-testing phase in 2023, this groundbreakin…
Read MoreCompleted Factory Acceptance Test and Now Working Toward Commercial OperationsDALLAS, TX / ACCESSWIRE / February 5, 2024 / Vivakor, Inc. (Nasdaq:VIVK) (“Vivakor” or the “Company”), a clean energy technology company focused on the oi…
Read MoreBOSTON, MA / ACCESSWIRE / February 5, 2024 / Physician Growth Partners (“PGP”), a leading sell-side healthcare investment banking and transaction advisory firm, is pleased to announce the promotion of Robert Aprill to the position of Partner …
Read MoreABBOTT PARK, IL / ACCESSWIRE / February 5, 2024 / Abbott:AbbottThe PROTALITY™ brand provides nutritional support for adults pursuing weight loss in the form of a high-protein nutrition shake featuring a blend of fast- and slow-digesting protein designe…
Read MoreLOS ANGELES, CA / ACCESSWIRE / February 5, 2024 / The Ohana, a world-class detox and residential inpatient treatment program, announces plans for expansion in 2024. In response to unprecedented demand for its services, The Ohana will be adding four add…
Read More